据近期出版的《眼科学》杂志报道,新的研究结果表明Daclizumab可用以治疗眼部炎症,并已取得显著疗效。众所周知,一些眼部炎症需要使用免疫抑制剂治疗以控制炎症造成的严重病损。通常使用的免疫抑制剂有氨甲喋呤、硫唑嘌呤、环孢霉素、他克莫司、麦考酚酸酯、苯丁酸氮芥、环磷酰胺以及静脉内注射免疫球蛋白。然而,有些患者经过这些药物治疗后仍无法控制其炎症,甚至还出现了严重的毒副反应以至不得不停止治疗。 According to a recent issue of Ophthalmology, new findings show that Daclizumab can be used to treat ocular inflammation and has achieved significant results. It is well-known that some ocular inflammations require the use of immunosuppressive agents to control severe lesions caused by inflammation. Commonly used immunosuppressive agents are methotrexate, azathioprine, cyclosporine, tacrolimus, mycophenolate mofetil, chlorambucil, cyclophosphamide, and intravenous immunoglobulin. However, some patients are unable to control their inflammation after these medications, and even have serious side effects that have to stop treatment.